Business Description
Bukwang Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : KR7003000007
Share Class Description:
XKRX:003000: Ordinary SharesCompare
Compare
Traded in other countries / regions
003000.Korea IPO Date
1988-08-05Description
Bukwang Pharmaceutical Co Ltd manufactures and markets medicines for diabetes, hepatitis B, anticancer and psychiatry. The Company's OTC products focus on dental treatment. The company also engages in venture business and bio engineering.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.91 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.35 | |||||
| Debt-to-EBITDA | -2.52 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 2.44 | |||||
| Beneish M-Score | -4.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.4 | |||||
| 3-Year EBITDA Growth Rate | -269.2 | |||||
| 3-Year EPS without NRI Growth Rate | -163.7 | |||||
| 3-Year FCF Growth Rate | -115 | |||||
| 3-Year Book Growth Rate | -7.3 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.51 | |||||
| 9-Day RSI | 48.95 | |||||
| 14-Day RSI | 46.25 | |||||
| 6-1 Month Momentum % | 18.79 | |||||
| 12-1 Month Momentum % | -16.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.61 | |||||
| Quick Ratio | 2.02 | |||||
| Cash Ratio | 1.55 | |||||
| Days Inventory | 230.03 | |||||
| Days Sales Outstanding | 204.06 | |||||
| Days Payable | 43.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.2 | |||||
| Shareholder Yield % | -5.93 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 37.38 | |||||
| Operating Margin % | -29.78 | |||||
| Net Margin % | -24.88 | |||||
| FCF Margin % | -9.69 | |||||
| ROE % | -12.52 | |||||
| ROA % | -7.85 | |||||
| ROIC % | -11.17 | |||||
| ROC (Joel Greenblatt) % | -17.64 | |||||
| ROCE % | -10.16 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 26.65 | |||||
| PS Ratio | 3.35 | |||||
| PB Ratio | 1.87 | |||||
| Price-to-Tangible-Book | 1.96 | |||||
| EV-to-EBIT | -9.84 | |||||
| EV-to-EBITDA | -11.18 | |||||
| EV-to-Revenue | 2.79 | |||||
| EV-to-FCF | -27.73 | |||||
| Price-to-Projected-FCF | 2.32 | |||||
| Price-to-Median-PS-Value | 0.55 | |||||
| Price-to-Net-Current-Asset-Value | 8.23 | |||||
| Earnings Yield (Greenblatt) % | -10.16 | |||||
| FCF Yield % | -2.87 | |||||
| Forward Rate of Return (Yacktman) % | -33.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bukwang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 125,928.241 | ||
| EPS (TTM) (â‚©) | -469 | ||
| Beta | 0.92 | ||
| Volatility % | 18.84 | ||
| 14-Day RSI | 46.25 | ||
| 14-Day ATR (â‚©) | 259.947072 | ||
| 20-Day SMA (â‚©) | 6294 | ||
| 12-1 Month Momentum % | -16.15 | ||
| 52-Week Range (â‚©) | 5460 - 9000 | ||
| Shares Outstanding (Mil) | 68.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bukwang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bukwang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bukwang Pharmaceutical Co Ltd Frequently Asked Questions
What is Bukwang Pharmaceutical Co Ltd(XKRX:003000)'s stock price today?
The current price of XKRX:003000 is â‚©6190.00. The 52 week high of XKRX:003000 is â‚©9000.00 and 52 week low is â‚©5460.00.
When is next earnings date of Bukwang Pharmaceutical Co Ltd(XKRX:003000)?
The next earnings date of Bukwang Pharmaceutical Co Ltd(XKRX:003000) is .
Does Bukwang Pharmaceutical Co Ltd(XKRX:003000) pay dividends? If so, how much?
Bukwang Pharmaceutical Co Ltd(XKRX:003000) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers